Marc Wilson - 31 Dec 2024 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
CFO
Signature
Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
31 Dec 2024
Transactions value $
$7,086
Form type
5
Filing time
29 Jan 2025, 16:30:04 UTC
Previous filing
30 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $7,085 +473 +0.43% $14.98 111,565 20 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),